EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjunctive role of p16/Ki-67 dual-stain cytology in colposcopy referral pathways for cervical precancer and persistent high-risk HPV infection

Yingying Yue, Xuewang Guo, Yu Dou, Xiaowen Wu, Weina Yang, Yanying Xu

Frontiers in Oncology · 13.07.2026 · 16

DOI: 10.3389/fonc.2026.1794191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 13.07.2026. Verfasst von Yingying Yue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Second Hospital of Tianjin Medical University, Tianjin, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the adjunctive triage performance of p16/Ki-67 dual staining (DS) cytology for cervical lesions in a colposcopy-referred cohort, to analyze its correlation with lesion severity, and to explore its predictive value for persistent high-risk human papillomavirus (HR-HPV) infection.

Methods

A total of 109 patients undergoing colposcopic cervical biopsy (recruited via standard HPV+TCT referral criteria) were included. We evaluated the incremental diagnostic performance of adding p16/Ki-67 dual-stain (DS) triage to the standard HPV+TCT referral workflow for detection of CIN2+ and CIN3 +. Among 66 HR-HPV-positive patients with CIN1 or lower lesions, p16/Ki-67 DS cytology was performed, and the patients were followed up for 6 months to assess the predictive value for persistent infection.

Results

The positivity rate of p16/Ki-67 DS cytology gradually increased with the progression of cervical lesion severity (P<0.001). Further triage with p16/Ki-67 DS on the basis of combined HPV+TCT cervical cancer screening yielded sensitivity, specificity, accuracy and AUC of 77.8%, 88.6%, 84.4% and 0.822 ± 0.052 (95%CI: 0.721–0.923) for the diagnosis of CIN2+, and 93.3%, 81.3%, 81.7% and 0.823 ± 0.056 (95%CI: 0.713–0.933) for CIN3+, respectively. Among HR-HPV-positive CIN1/lower lesions, 87.1% of DS-positive patients had persistent infection compared to 62.9% of DS-negative patients (P = 0.025), with an odds ratio of 4.515 (P = 0.028).

Conclusions

In this colposcopy-referred cohort defined by HPV and/or TCT-based referral criteria, p16/Ki-67 dual-stain (DS) cytology exhibited satisfactory adjunctive triage efficacy for identifying CIN2+ and CIN3+, and independently predicted persistent HR-HPV infection among patients with ≤CIN1 lesions. Notably, all analyses in this study are limited to diagnostic efficacy in this referral cohort; any potential clinical applications, including possible reductions in unnecessary procedures, remain exploratory hypotheses that require prospective clinical validation.

Schlagwörter

Stichwörter der Autor:innen

HPV infectionantigen Ki67cervical cancerp16 (INK4a)uterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Gynecology, The Second Hospital of Tianjin Medical University, Tianjin, China.

Zitieren

APA

Yue, Y., Guo, X., Dou, Y., Wu, X., Yang, W., & Xu, Y. (2026). Adjunctive role of p16/Ki-67 dual-stain cytology in colposcopy referral pathways for cervical precancer and persistent high-risk HPV infection. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1794191

Vancouver

Yue Y, Guo X, Dou Y, Wu X, Yang W, Xu Y. Adjunctive role of p16/Ki-67 dual-stain cytology in colposcopy referral pathways for cervical precancer and persistent high-risk HPV infection. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1794191

BibTeX
@article{Yue2026,
  author = {Yue, Yingying and Guo, Xuewang and Dou, Yu and Wu, Xiaowen and Yang, Weina and Xu, Yanying},
  title = {Adjunctive role of p16/Ki-67 dual-stain cytology in colposcopy referral pathways for cervical precancer and persistent high-risk HPV infection},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1794191}
}
Kostenlos starten →